Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)β’ Click on a phase to view related trials
COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability
- Conditions
- Sars-CoV-2 InfectionCOVID-19
- First Posted Date
- 2022-10-18
- Last Posted Date
- 2023-06-02
- Lead Sponsor
- MP Biomedicals, LLC
- Target Recruit Count
- 99
- Registration Number
- NCT05584189
- Locations
- πΊπΈ
EDP Biotech Corporation, Knoxville, Tennessee, United States
COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation
- Conditions
- COVID-19SARS-CoV2 Infection
- First Posted Date
- 2022-10-18
- Last Posted Date
- 2023-06-01
- Lead Sponsor
- MP Biomedicals, LLC
- Target Recruit Count
- 332
- Registration Number
- NCT05584176
- Locations
- πΊπΈ
Accel Research, DeLand, Florida, United States
πΊπΈDaniel Sarkis, Gainesville, Florida, United States
πΊπΈAccel Research Site St. Petersburg, Saint Petersburg, Florida, United States
MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study
- Conditions
- HTLV I Associated T Cell Leukemia LymphomaHTLV-I InfectionsHuman T-lymphotropic Virus 1HTLV I Associated MyelopathiesHuman T-lymphotropic Virus 2HTLV-II Infections
- First Posted Date
- 2017-07-21
- Last Posted Date
- 2018-09-13
- Lead Sponsor
- MP Biomedicals, LLC
- Target Recruit Count
- 150
- Registration Number
- NCT03226119
- Locations
- πΊπΈ
LABS, Inc., Philadelphia, Pennsylvania, United States
πΊπΈQualtex Laboratories, San Antonio, Texas, United States
πΊπΈEastern Virginia Medical School (EVMS), Norfolk, Virginia, United States
Dual Algorithm Post Market Clinical Study
- Conditions
- Human T-lymphotropic Virus 2Human T-lymphotropic Virus 1HTLV I Associated T Cell Leukemia LymphomaHTLV-I InfectionsHTLV-II InfectionsHTLV I Associated Myelopathies
- First Posted Date
- 2017-05-09
- Last Posted Date
- 2017-06-12
- Lead Sponsor
- MP Biomedicals, LLC
- Target Recruit Count
- 100
- Registration Number
- NCT03146013
- Locations
- πΊπΈ
American Red Cross - National Testing Laboratory, Charlotte, North Carolina, United States
Evaluation of the MP Diagnostics HTLV Blot 2.4
- Conditions
- HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1Human T-lymphotropic Virus 2HTLV I Associated T Cell Leukemia LymphomaHTLV I Associated Myelopathies
- First Posted Date
- 2011-11-08
- Last Posted Date
- 2011-11-08
- Lead Sponsor
- MP Biomedicals, LLC
- Target Recruit Count
- 600
- Registration Number
- NCT01467024
- Locations
- πΊπΈ
California Department of Public Health, Richmond, California, United States
πΊπΈLABS, Inc, St. Louis, Missouri, United States